AGEN AGEN

Q: What is the current share price of AGEN?

As of 2026-08-05 17:25 PDT, AGEN trades at $7.78 on NASDAQ/NYSE. Its 52-week range is $2.77 to $8.30.

Q: What is the market capitalisation of AGEN?

AGEN has a market capitalisation of $274.79M on NASDAQ/NYSE.

Q: What is the return on equity (ROE) of AGEN?

AGEN has a return on equity (ROE) of -0.04%. Its return on capital employed (ROCE) is 21.26%.

Q: Is AGEN a good stock to buy?

This page provides a data-driven analysis of AGEN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$7.78

+44.07% 1Y

Mkt Cap$274.79M

P/B-1.01

52W High$8.30

52W Low$2.77

Book Value$-7.68

Company Overview

AGEN (AGEN) is a publicly traded company listed on with a market capitalization of $274.79M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 21.3%.

Steady Revenue Expansion

Revenue has grown at a 26.6% CAGR over the past five years.

Recent Developments

Dec 2025 Revenue of $114.20M (+10.4% YoY); net profit $115.00K.
Trailing 12 Months Year-on-year growth — revenue +10.4%.
5-Year Trend Long-term compounding — revenue CAGR 26.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	26.56%
1 Year:	10.37%

Stock Price Performance

1 Year:	+44.07%
6 Months:	+168.28%
3 Months:	+86.57%
1 Month:	+122.29%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 91% of range

$2.77 $8.30

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
Golden Cross8d ago
RSI (14)70.49 · Overbought

Price Performance

1M+122.29%

3M+86.57%

6M+168.28%

1Y+44.07%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Healthy ROCE of 21.3%.
Compounding revenue at 26.6% over 5 years.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

Industry PE

Forward P/E

PEG Ratio

Book Value

$-7.68

Price to Book

-1.01

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

26.56%

Profit 5Y

Revenue (YoY)

10.37%

Earnings (YoY)

Profitability & Returns

ROCE

21.26%

ROE

-0.04%

ROA

0.05%

Profit Margin

0.10%

Op Margin

-18.00%

Gross Margin

29.63%

EPS (Latest Qtr)

$1.02

EPS (TTM)

$0.00

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

Current Ratio

0.41

Debt

$55.90M

Total Assets

$186.46M

Current Assets

$95.28M

Working Capital

$-190.05M

Ownership

Promoter Holding

Chg in Prom Hold

FII / Inst Holding

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$114.20M

EBITDA

$62.19M

Free Cash Flow

$-77.20M

Operating Cash Flow

$-77.19M

Shares Outstanding

35.32M

Gross Margin

29.63%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	26.96M	4.21M	3.36M	8.35M	1.64M	15.89M	12.80M	6.45M	79.89M	15.71M	19.94M	34.50M	15.13M	26.95M	14.83M	31.27M	11.72M	10.73M	252.95M	25.94M	20.93M	22.77M	22.90M	25.30M	24.31M	28.00M	23.51M	25.11M	24.07M	25.69M	30.23M	34.20M	33.74M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.66M	26.95M	24.24M	7.51M	11.82M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.41M	-1.26M	6.00M	26.69M	21.91M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.72M	15.52M	10.86M	12.29M	6.86M
Operating Income	-33.20M	-11.07M	-	-27.97M	-23.61M	-36.22M	-	-13.26M	-28.89M	-31.66M	-	-41.75M	-16.57M	-26.07M	-	26.21M	-41.15M	-35.92M	-	-27.46M	-33.27M	-34.79M	-	-41.37M	-66.39M	187.54M	-35.46M	-44.56M	-41.65M	-54.34M	-54.67M	-46.34M	-32.88M	-30.19M	-31.50M	-13.31M	-16.78M	-4.86M	14.40M	15.05M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10.37M	-13.55M	80.11M	6.00M	54.46M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.79M	13.29M	13.17M	16.02M	14.67M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-26.37M	-30.01M	63.91M	-10.61M	39.21M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-40.41M	-13.12M	-15.61M	-31.78M	-28.32M	-40.77M	-26.12M	-17.10M	-31.71M	-36.84M	-35.03M	-54.26M	-25.20M	-33.73M	-48.85M	17.43M	-51.87M	-46.28M	-30.85M	-45.27M	-48.24M	-51.65M	-37.73M	-	-	-	-	-	-	-	-	-	-	-	-	-25.27M	-27.95M	63.91M	-10.58M	39.23M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-0.53	-	-	-	0.12	-0.38	-0.33	-0.22	-0.31	-	-0.28	-	-	-0.37	0.72	-0.19	-0.17	-0.19	-4.31	-3.93	-3.29	-3.04	-2.52	-3.08	-1.03	-1.00	1.94	-	1.02
R&D Expense	24.77M	18.50M	-	25.04M	22.36M	21.59M	-	32.64M	25.82M	25.79M	-	29.44M	29.27M	29.85M	-	40.13M	45.24M	46.13M	-	36.36M	38.55M	32.13M	-	36.68M	45.51M	42.94M	42.44M	44.96M	46.01M	57.12M	59.28M	51.44M	43.92M	36.77M	41.06M	21.52M	26.71M	23.60M	-	11.82M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	3.33M	3.36M	2.76M	15.96M	3.05M	6.98M	24.82M	22.57M	42.88M	36.78M	150.05M	88.17M	-	98.02M	156.31M	103.46M	114.20M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	197.26M	237.68M	156.01M	80.36M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-99.23M	-81.37M	-52.55M	33.84M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	81.01M	78.74M	71.88M	54.39M
Operating Income	-27.68M	-21.75M	-19.09M	-6.74M	-24.98M	-43.32M	-80.70M	-107.48M	-103.80M	-123.82M	-70.14M	-117.23M	-	-180.24M	-160.10M	-124.43M	-20.56M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-161.85M	-145.92M	-101.30M	62.19M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	61.86M	97.92M	117.63M	55.27M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-230.66M	-257.44M	-232.27M	-3.08M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-30.32M	-21.91M	-23.28M	-11.32M	-30.07M	-42.49M	-87.88M	-127.00M	-120.69M	-159.90M	-107.86M	-181.12M	-	-220.07M	-245.76M	-227.21M	115.00K
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-1.05	-	-15.64	-13.75	-10.59	0.00
R&D Expense	16.90M	12.88M	11.02M	10.56M	13.01M	22.35M	70.44M	94.97M	116.12M	124.60M	168.34M	142.62M	178.61M	186.69M	234.57M	155.53M	79.34M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Jan 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	30.91M	19.81M	29.09M	34.84M	74.53M	242.23M	-	-	-	156.99M	-	-	-	138.40M	-	136.40M	155.34M	214.51M	-	413.56M	313.91M	226.27M	226.80M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	213.12M	112.42M	45.57M	133.44M
Cash & Equivalents	24.47M	20.07M	19.78M	10.75M	21.47M	27.35M	25.71M	136.70M	148.20M	123.30M	95.40M	71.45M	123.80M	96.80M	70.10M	60.19M	86.80M	53.05M	61.81M	99.87M	-	178.67M	76.11M	40.44M	3.00M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.74M	25.84M	407.00K	1.83M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	468.46M	462.30M	532.70M	504.66M
Current Liabilities	-	-	5.42M	4.75M	4.81M	10.30M	9.23M	28.93M	-	-	-	40.85M	-	-	-	56.44M	-	68.06M	122.21M	129.88M	-	188.95M	255.90M	221.40M	323.49M
Long Term Debt	-	-	-	-	-	-	4.77M	114.33M	-	-	-	130.54M	-	-	-	142.39M	-	13.21M	13.38M	18.88M	12.82M	12.58M	12.77M	30.47M	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78.43M	88.47M	94.87M	55.90M
Total Equity	-20.33M	-16.97M	-14.71M	-20.83M	-17.60M	-4.48M	23.02M	70.73M	-	-	-	-39.13M	-	-	-	-75.82M	-	-172.47M	-225.36M	-203.67M	-	-61.28M	-160.33M	-326.38M	-271.11M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.28M	19.72M	23.63M	35.32M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-24.19M	-14.76M	-16.25M	1.01M	-19.53M	-38.23M	-	-79.96M	-94.23M	-131.09M	-18.68M	-139.10M	10.14M	-175.37M	-224.20M	-158.31M	-77.19M
Investing Cash Flow	2.16M	9.93M	-29.46K	-103.44K	-363.52K	-16.81M	-	17.60M	2.06M	-3.59M	-4.66M	-4.44M	-43.15M	-33.61M	3.40M	27.00K	1.19M
Financing Cash Flow	17.63M	4.54M	7.24M	9.81M	25.78M	52.81M	-	-2.46M	80.54M	128.29M	31.32M	183.85M	225.26M	95.83M	119.87M	122.84M	36.59M
Capital Expenditure	-243.87K	-130.44K	-54.55K	-103.44K	-813.52K	-2.82M	-3.59M	-12.52M	-3.12M	-3.60M	-4.66M	-3.47M	-33.81M	-53.06M	-9.95M	-576.00K	-6.00K
Free Cash Flow	-24.44M	-14.89M	-16.30M	909.16K	-20.35M	-41.05M	-	-92.48M	-97.35M	-134.69M	-23.34M	-142.56M	-23.67M	-228.44M	-234.16M	-158.89M	-77.20M
Share Buybacks	54.94K	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-101.2%	-52.1%	-50.8%	29.6%
Operating Margin %	-830.1%	-647.5%	-692.6%	-42.2%	-820.3%	-620.9%	-325.2%	-476.1%	-242.1%	-336.6%	-46.7%	-133.0%	-	-183.9%	-102.4%	-120.3%	-18.0%
Net Margin %	-909.2%	-652.0%	-844.6%	-71.0%	-987.5%	-608.9%	-354.1%	-562.6%	-281.5%	-434.7%	-71.9%	-205.4%	-	-224.5%	-157.2%	-219.6%	0.1%
ROE %	178.6%	148.9%	111.7%	64.3%	671.2%	-184.6%	-124.3%	324.6%	159.2%	92.7%	47.9%	88.9%	-	359.1%	153.3%	69.6%	-0.0%
ROCE %	-	-85.3%	-126.8%	-27.8%	-101.8%	-66.3%	-37.8%	-92.5%	-126.6%	-181.2%	-211.7%	-138.5%	-	-80.2%	-276.0%	-2,555.0%	21.3%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AGEN

Google News ue, 28 Jul 2026

AGENUS INC SEC Filing (Jul 28, 2026) - Stock Titan

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOLXJ2ZFJ6VGtER0t2akJnamYtbGdPVVFFeVlEbU5uMlMwLVYyUU5uOGMxRF9TVjF6QnFZdXQxajU0R3lyMXBhWFF1R2lfZk9QckJreTY2LXVMeHA2OGtaQXBxZDBjQUpjY0RrazBFZVpkMVQyMGNrVGxNQ0V6cHlDTlQ2ZERHSFlMOFdJaW…

Google News Mon, 13 Jul 2026

Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN) - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQNjg0aG84RlROQkMxc2xNcjdoMnRHRU10OUplb3dwbzJkOFZVcEJJWXdxT0NrUkVQdDdKTUtTOW9iOW9zTFltbllDNV9Pd0VTb01FMWUwam5fWkhpaVJZaEFrTHVLM19ocDlSUUFaNGVFZTR5VGVObXlzY1RDQ0xCSlVwR2I2d0Y5Y29UcH…

Google News Mon, 13 Jul 2026

AGEN Stock Rockets As Phase 1b Data De-Risk BATTMAN Trial - StocksToTrade

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE9LRFY5aU9abDdtMmZhSGFuMnpEZlI4TEZYWFYyU0F4TmxsU3Z3Q3ctU243S09YRExVeXFkb2pnUGV3OHFzcUktcW8wMXUxTmtkNXlackNFb3Z1cjVnaGZKZFRMNV9RenpvSWFNQ29lWTk?oc=5" target="_blank">AGEN Stock Rocke…

Google News Fri, 31 Jul 2026

AGEN|Agenus Inc|Price:7.810|Chg%:+0.310 - TradingKey

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBCejlrZF9NeDBiNW9OdmZydDVvMW1jeWJKNnVKMHNrU3htODhVZVhzdDBaM1hVSEV5bDJuMHU4QTJFYlBmVGFtZUhSdlRna2pVNGhoLWQycUlRUQ?oc=5" target="_blank">AGEN|Agenus Inc|Price:7.810|Chg%:+0.310</a>&n…

Google News hu, 21 May 2026

AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNR1I4UkRJN3p4dW9xT1lmVVhfeFhkenF6c2pPOVZCMUJEY3BjRmJtZDRXVHJuN3hUcUd3cU5qRUJpdHVyaUZ5ME1vNFI2SmFqUms5M2FzWEc5aVRoNzJDbXpkclZaekVxSGg3V1lnbHdTYk5JMnl3U0gzWTJhOW1oMjdpeDJJTXQ0VU5aaV…

Google News ue, 28 Jul 2026

Agenus plans August webcast on BOT+BAL colon cancer trial - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQUVNFV1BieF8wVVdlUDJHLVpkQTJ5MFR2YUowU2l5RklrZmU5SjhMWURBelVMXzhWTVp0Z240dXp5dG1SMXFKU1JBVnVtS1ZYT2tGdlpxR0F3YlQ0RnRVLXZYR2RBSm12bExiQ091cWNNRzB2czdIR3AxV1pzNHlJUmNyb2Y4dFVRcEtCVD…

AGEN — Frequently Asked Questions

What is the current share price of AGEN?

As of 2026-08-05 17:25 PDT, AGEN trades at $7.78 on NASDAQ/NYSE. Its 52-week range is $2.77 to $8.30.

What is the market capitalisation of AGEN?

AGEN has a market capitalisation of $274.79M on NASDAQ/NYSE.

What is the return on equity (ROE) of AGEN?

AGEN has a return on equity (ROE) of -0.04%. Its return on capital employed (ROCE) is 21.26%.

Is AGEN a good stock to buy?

This page provides a data-driven analysis of AGEN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

AGEN AGEN

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Analyst View

Latest News

AGENUS INC SEC Filing (Jul 28, 2026) - Stock Titan

Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN) - Yahoo Finance

AGEN Stock Rockets As Phase 1b Data De-Risk BATTMAN Trial - StocksToTrade

AGEN|Agenus Inc|Price:7.810|Chg%:+0.310 - TradingKey

AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell? - Yahoo Finance

Agenus plans August webcast on BOT+BAL colon cancer trial - Stock Titan

AGEN — Frequently Asked Questions

What is the current share price of AGEN?

What is the market capitalisation of AGEN?

What is the return on equity (ROE) of AGEN?

Is AGEN a good stock to buy?

Explore More